Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00036127
What this trial is testing

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc.
Not applicableUnknownNCT02932059
What this trial is testing

Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia

Who this might be right for
SchizophreniaAging
University Hospital, Clermont-Ferrand 120
Not applicableStudy completedNCT02594696
What this trial is testing

Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness

Who this might be right for
Major DepressionSchizophreniaBipolar Disorder+5 more
Massachusetts General Hospital 30
Post-approval studies (Phase 4)Study completedNCT06041646
What this trial is testing

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder

Who this might be right for
Bipolar DisorderSchizophreniaAgitation,Psychomotor+2 more
BioXcel Therapeutics Inc 29
Not applicableStudy completedNCT04221269
What this trial is testing

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

Who this might be right for
SchizophreniaSuicide
Butler Hospital 30
Not applicableStudy completedNCT05473741
What this trial is testing

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Who this might be right for
SchizophreniaSchizophrenia Relapse
Centre for Addiction and Mental Health 51
Post-approval studies (Phase 4)Ended earlyNCT01592201
What this trial is testing

A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 13
Large-scale testing (Phase 3)Study completedNCT00600756
What this trial is testing

Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone

Who this might be right for
Schizophrenic Disorders
AstraZeneca 798
Large-scale testing (Phase 3)Study completedNCT00523445
What this trial is testing

The Effects of Varenicline on Cognitive Function in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Inje University 120
Large-scale testing (Phase 3)Study completedNCT00843687
What this trial is testing

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 188
Not applicableUnknownNCT05448430
What this trial is testing

ITBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.

Who this might be right for
Schizophrenia
Central South University 50
Testing effectiveness (Phase 2)Study completedNCT01548612
What this trial is testing

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

Who this might be right for
Schizophrenia
University of Sao Paulo 20
Testing effectiveness (Phase 2)Study completedNCT00149292
What this trial is testing

Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo

Who this might be right for
Schizophrenia
Denovo Biopharma LLC 195
Early research (Phase 1)Study completedNCT02411526
What this trial is testing

Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Zogenix, Inc. 60
Not applicableStudy completedNCT04941352
What this trial is testing

Motivational Interviewing in Patients With Schizophrenia

Who this might be right for
Motivational InterviewsSchizophrenia
Pamukkale University 40
Testing effectiveness (Phase 2)Study completedNCT03425552
What this trial is testing

A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment

Who this might be right for
Schizophrenia
Pharmathen S.A. 70
Not applicableLooking for participantsNCT03911726
What this trial is testing

Do Antipsychotic Agents Induce Supersensitivity in Humans: A Combined PET/MRI Study in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 140
Testing effectiveness (Phase 2)Study completedNCT00768326
What this trial is testing

Efficacy of Lu 31-130 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
H. Lundbeck A/S 280
Large-scale testing (Phase 3)Study completedNCT00113594
What this trial is testing

Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Eli Lilly and Company 100
Testing effectiveness (Phase 2)Study completedNCT01852331
What this trial is testing

Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizophrenic DisorderHyperprolactinemia+1 more
The University of Hong Kong 103
Next Page